Trial Information
Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment
Inclusion Criteria:
1. - Hepatocellular carcinoma patients who will undergo TACE and/or radio-frequency.
2. - Fever more than 38C after 48 hours post intervention.
Exclusion Criteria:
1. HCC Patients who does not develop fever after intervention.
2. Proven infection elsewhere (e.g. UTI, chest infection..)
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Differantiate between post- embolization syndrom and sepsis following locoregional treatment for hepatocellular carcinoma
Outcome Time Frame:
6months
Safety Issue:
Yes
Principal Investigator
Hisham K Dabbous, professor
Investigator Role:
Principal Investigator
Investigator Affiliation:
Tropical medicine department
Authority:
Egypt: Institutional Review Board
Study ID:
iman montasser
NCT ID:
NCT01518829
Start Date:
April 2012
Completion Date:
January 2013
Related Keywords:
- Hepatocellular Carcinoma
- hepatocellular carcinom
- postablation syndrom
- procalcitonin
- Carcinoma
- Carcinoma, Hepatocellular